PEDF and its roles in physiological and pathological conditions: Implication in diabetic and hypoxia-induced angiogenic diseases

Clinical Science

Volumn 128, Issue 11, 2015, Pages 805-823

  He, Xuemin ^a   Cheng, Rui ^a   Benyajati, Siribhinya ^a   Ma, Jian Xing ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Diabetes; Hypoxia; PEDF receptor; Pigment epithelium derived factor (PEDF); Serpin; Tissue distribution

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALKALINE PHOSPHATASE; BETA CATENIN; CASPASE 8; DESNUTRIN; FIBROBLAST GROWTH FACTOR 2; FLICE INHIBITORY PROTEIN; GAMMA SECRETASE; GELATINASE A; GELATINASE B; INTEGRIN; LAMININ RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 9; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIGMENT EPITHELIUM DERIVED FACTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RECEPTOR INTERACTING PROTEIN 140; RETINOID X RECEPTOR; SCLEROSTIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; WNT PROTEIN; ANGIOGENESIS INHIBITOR; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ANGIOGENESIS; APOPTOSIS; BONE; CORNEA NEOVASCULARIZATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FATTY LIVER; FIBROGENESIS; FIBROSING ALVEOLITIS; HUMAN; HYPERGLYCEMIA; HYPOXIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY; LASER-INDUCED CHOROIDAL NEOVASCULARIZATION; LIVER; LUNG; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOGENESIS IMPERFECTA; OXYGEN-INDUCED RETINOPATHY; PANCREAS; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; RETINA NEOVASCULARIZATION; RETINITIS; REVIEW; ADULT; ANOXIA; GENE EXPRESSION PROFILING; GENETICS; NEOVASCULARIZATION, PATHOLOGIC; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT; ANGIOGENESIS INHIBITORS; ANOXIA; DIABETES MELLITUS; EYE PROTEINS; GENE EXPRESSION PROFILING; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; SERPINS; SIGNAL TRANSDUCTION;

EID: 84930974284     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20130463     Document Type: Review

References (258)

1. Pignolo, R.J., Cristofalo, V.J. and Rotenberg, M.O. (1993) Senescent WI-38 cells fail to express EPC-1, a gene induced in young cells upon entry into the G0 state. J. Biol. Chem. 268, 8949-8957
2. Pignolo, R.J., Rotenberg, M.O. and Cristofalo, V.J. (1995) Analysis of EPC-1 growth state-dependent expression, specificity, and conservation of related sequences. J. Cell Physiol. 162, 110-118
3. Tombran-Tink, J. and Johnson, L.V. (1989) Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest. Ophthalmol. Vis. Sci. 30, 1700-1707
4. Tombran-Tink, J., Chader, G.G. and Johnson, L.V. (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res. 53, 411-414
5. Tombran-Tink, J., Aparicio, S., Xu, X., Tink, A.R., Lara, N., Sawant, S., Barnstable, C.J. and Zhang, S.S. (2005) PEDF and the serpins: phylogeny, sequence conservation, and functional domains. J. Struct. Biol. 151, 130-150
6. Becerra, S.P., Sagasti, A., Spinella, P. and Notario, V. (1995) Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J. Biol. Chem. 270, 25992-25999
7. Becerra, S.P. (1997) Structure-function studies on PEDF. A noninhibitory serpin with neurotrophic activity. Adv. Exp. Med. Biol. 425, 223-237
8. Dawson, D.W., Volpert, O.V., Gillis, P., Crawford, S.E., Xu, H., Benedict, W. and Bouck, N.P. (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285, 245-248
9. Stellmach, V., Crawford, S.E., Zhou, W. and Bouck, N. (2001) Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc. Natl. Acad. Sci. U.S.A. 98, 2593-2597
10. Spranger, J., Osterhoff, M., Reimann, M., Mohlig, M., Ristow, M., Francis, M.K., Cristofalo, V., Hammes, H.P., Smith, G., Boulton, M. and Pfeiffer, A.F. (2001) Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 50, 2641-2645
11. Gao, G., Li, Y., Fant, J., Crosson, C.E., Becerra, S.P. and Ma, J.X. (2002) Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in brown Norway and Sprague Dawley rats contributing to different susceptibilities to retinal neovascularization. Diabetes 51, 1218-1225
12. Doll, J.A., Stellmach, V.M., Bouck, N.P., Bergh, A.R., Lee, C., Abramson, L.P., Cornwell, M.L., Pins, M.R., Borensztajn, J. and Crawford, S.E. (2003) Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat. Med. 9, 774-780
13. Crawford, S.E., Stellmach, V., Ranalli, M., Huang, X., Huang, L., Volpert, O., De Vries, G.H., Abramson, L.P. and Bouck, N. (2001) Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J. Cell. Sci. 114, 4421-4428
14. Abramson, L.P., Stellmach, V., Doll, J.A., Cornwell, M., Arensman, R.M. and Crawford, S.E. (2003) Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. J. Pediatr. Surg. 38, 336-342
15. Yokoi, M., Yamagishi, S., Saito, A., Yoshida, Y., Matsui, T., Saito, W., Hirose, S., Ohgami, K., Kase, M. and Ohno, S. (2007) Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy. Br. J. Ophthalmol. 91, 885-887
16. Boehm, B.O., Lang, G., Feldmann, B., Kurkhaus, A., Rosinger, S., Volpert, O., Lang, G.K. and Bouck, N. (2003) Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. a pilot study. Horm. Metab. Res. 35, 382-386
17. Boehm, B.O., Lang, G., Volpert, O., Jehle, P.M., Kurkhaus, A., Rosinger, S., Lang, G.K. and Bouck, N. (2003) Low content of the natural ocular anti-angiogenic agent pigment epitheliumderived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Diabetologia 46, 394-400
18. Ogata, N., Nishikawa, M., Nishimura, T., Mitsuma, Y. and Matsumura, M. (2002) Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am. J. Ophthalmol. 134, 348-353
19. Guan, M., Yam, H.F., Su, B., Chan, K.P., Pang, C.P., Liu, W.W., Zhang, W.Z. and Lu, Y. (2003) Loss of pigment epithelium derived factor expression in glioma progression. J. Clin. Pathol. 56, 277-282
20. Uehara, H., Miyamoto, M., Kato, K., Ebihara, Y., Kaneko, H., Hashimoto, H., Murakami, Y., Hase, R., Takahashi, R., Mega, S. et al. (2004) Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res. 64, 3533-3537
21. Zhang, L., Chen, J., Ke, Y., Mansel, R.E. and Jiang, W.G. (2006) Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Int. J. Mol. Med. 17, 937-944
22. Cai, J., Parr, C., Watkins, G., Jiang, W.G. and Boulton, M. (2006) Decreased pigment epithelium-derived factor expression in human breast cancer progression. Clin. Cancer Res. 12, 3510-3517
23. Holekamp, N.M., Bouck, N. and Volpert, O. (2002) Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am. J. Ophthalmol. 134, 220-227
24. Matsuyama, K., Ogata, N., Matsuoka, M., Shima, C., Wada, M., Jo, N. and Matsumura, M. (2008) Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy. Mol. Vis. 14, 992-996
25. Ogata, N., Matsuoka, M., Matsuyama, K., Shima, C., Tajika, A., Nishiyama, T., Wada, M., Jo, N., Higuchi, A., Minamino, K. et al. (2007) Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. J. Clin. Endocrinol. Metab. 92, 1176-1179
26. Chen, H.B., Jia, W.P., Lu, J.X., Bao, Y.Q., Li, Q., Lu, F.D., Lu, W., Yu, H.Y. and Xiang, K.S. (2007) Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy. Zhonghua Yi Xue Za Zhi 87, 1230-1233
27. Katakami, N., Kaneto, H., Yamasaki, Y. and Matsuhisa, M. (2008) Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy. Diabetes Res. Clin. Pract. 81, e4-e7
28. Venturi, G., Gandini, A., Monti, E., Dalle Carbonare, L., Corradi, M., Vincenzi, M., Valenti, M.T., Valli, M., Pelilli, E., Boner, A. et al. (2012) Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen. J. Bone Miner. Res. 27, 723-728
29. Bogan, R., Riddle, R.C., Li, Z., Kumar, S., Nandal, A., Faugere, M.C., Boskey, A., Crawford, S.E. and Clemens, T.L. (2013) A mouse model for human osteogenesis imperfecta type VI. J. Bone Miner. Res. 28, 1531-1536
30. Huang, Q., Wang, S., Sorenson, C.M. and Sheibani, N. (2008) PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration. Exp. Eye Res. 87, 226-241
31. Chung, C., Doll, J.A., Gattu, A.K., Shugrue, C., Cornwell, M., Fitchev, P. and Crawford, S.E. (2008) Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). J. Hepatol. 48, 471-478
32. Schmitz, J.C., Protiva, P., Gattu, A.K., Utsumi, T., Iwakiri, Y., Neto, A.G., Quinn, M., Cornwell, M.L., Fitchev, P., Lugea, A. et al. (2011) Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1. Am. J. Pathol. 179, 2990-2999
33. Shin, E.S., Sorenson, C.M. and Sheibani, N. (2013) PEDF expression regulates the pro-angiogenic and pro-inflammatory phenotype of the lung endothelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 306, 620-634
34. Duh, E.J., Yang, H.S., Haller, J.A., De Juan, E., Humayun, M.S., Gehlbach, P., Melia, M., Pieramici, D., Harlan, J.B., Campochiaro, P.A. and Zack, D.J. (2004) Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am. J. Ophthalmol. 137, 668-674
35. Yoshida, Y., Yamagishi, S., Matsui, T., Nakamura, K., Imaizumi, T., Yoshimura, K. and Yamakawa, R. (2007) Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy. Br. J. Ophthalmol. 91, 1133-1134
36. Tombran-Tink, J., Mazuruk, K., Rodriguez, I.R., Chung, D., Linker, T., Englander, E. and Chader, G.J. (1996) Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol. Vis. 2, 11
37. Becker, J., Semler, O., Gilissen, C., Li, Y., Bolz, H.J., Giunta, C., Bergmann, C., Rohrbach, M., Koerber, F., Zimmermann, K. et al. (2011) Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am. J. Hum. Genet. 88, 362-371
38. Chung, C., Shugrue, C., Nagar, A., Doll, J.A., Cornwell, M., Gattu, A., Kolodecik, T., Pandol, S.J. and Gorelick, F. (2009) Ethanol exposure depletes hepatic pigment epithelium-derived factor, a novel lipid regulator. Gastroenterology 136, 331-340
39. Sawant, S., Aparicio, S., Tink, A.R., Lara, N., Barnstable, C.J. and Tombran-Tink, J. (2004) Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature. Biochem. Biophys. Res. Commun. 325, 408-413
40. Borg, M.L., Andrews, Z.B., Duh, E.J., Zechner, R., Meikle, P.J. and Watt, M.J. (2011) Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 60, 1458-1466
41. Crowe, S., Wu, L.E., Economou, C., Turpin, S.M., Matzaris, M., Hoehn, K.L., Hevener, A.L., James, D.E., Duh, E.J. and Watt, M.J. (2009) Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell Metab. 10, 40-47
42. Ho, T.C., Chen, S.L., Shih, S.C., Wu, J.Y., Han, W.H., Cheng, H.C., Yang, S.L. and Tsao, Y.P. (2010) Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells. Am. J. Pathol. 177, 1798-1811
43. Gattu, A.K., Birkenfeld, A.L., Jornayvaz, F., Dziura, J., Li, F., Crawford, S.E., Chu, X., Still, C.D., Gerhard, G.S., Chung, C. and Samuel, V. (2012) Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patients. Acta Diabetol. 49 (Suppl. 1), S161-S169
44. Jenkins, A.J., Zhang, S.X., Rowley, K.G., Karschimkus, C.S., Nelson, C.L., Chung, J.S., O'Neal, D.N., Januszewski, A.S., Croft, K.D., Mori, T.A. et al. (2007) Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes. Diabet. Med. 24, 1345-1351
45. Jenkins, A., Zhang, S.X., Gosmanova, A., Aston, C., Dashti, A., Baker, M.Z., Lyons, T. and Ma, J.X. (2008) Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Res. Clin. Pract. 82, e5-e7
46. Nakamura, K., Yamagishi, S., Adachi, H., Kurita-Nakamura, Y., Matsui, T. and Inoue, H. (2009) Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. Diabetes Metab. Res. Rev. 25, 52-56
47. Jenkins, A.J., Fu, D., Azar, M., Stoner, J.A., Kaufman, D.G., Zhang, S., Klein, R.L., Lopes-Virella, M.F., Ma, J.X., Lyons, T.J. and VATD Investigators, (2014) Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. J. Diabetes Complications 28, 353-359
48. Basu, R., Chandramouli, V., Dicke, B., Landau, B. and Rizza, R. (2005) Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 54, 1942-1948
49. Boden, G., Cheung, P. and Homko, C. (2003) Effects of acute insulin excess and deficiency on gluconeogenesis and glycogenolysis in type 1 diabetes. Diabetes 52, 133-137
50. Torres, T.P., Fujimoto, Y., Donahue, E.P., Printz, R.L., Houseknecht, K.L., Treadway, J.L. and Shiota, M. (2011) Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats. Diabetes 60, 2225-2233
51. Samkharadze, T., Erkan, M., Reiser-Erkan, C., Demir, I.E., Kong, B., Ceyhan, G.O., Michalski, C.W., Esposito, I., Friess, H. and Kleeff, J. (2011) Pigment epithelium-derived factor associates with neuropathy and fibrosis in pancreatic cancer. Am. J. Gastroenterol. 106, 968-980
52. Grippo, P.J., Fitchev, P.S., Bentrem, D.J., Melstrom, L.G., Dangi-Garimella, S., Krantz, S.B., Heiferman, M.J., Chung, C., Adrian, K., Cornwell, M.L. et al. (2012) Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut 61, 1454-1464
53. Cosgrove, G.P., Brown, K.K., Schiemann, W.P., Serls, A.E., Parr, J.E., Geraci, M.W., Schwarz, M.I., Cool, C.D. and Worthen, G.S. (2004) Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am. J. Respir. Crit. Care Med. 170, 242-251
54. Chetty, A., Bennett, M., Dang, L., Nakamura, D., Cao, G.J., Mujahid, S., Volpe, M., Herman, I., Becerra, S.P. and Nielsen, H.C. (2014) Pigment epithelium-derived factor mediates impaired lung vascular development in neonatal hyperoxia. Am. J. Respir. Cell Mol. Biol., doi:10.1165/rcmb.2013-0229OC
55. Hanumegowda, C., Farkas, L. and Kolb, M. (2012) Angiogenesis in pulmonary fibrosis: too much or not enough? Chest 142, 200-207
56. Quan, G.M., Ojaimi, J., Li, Y., Kartsogiannis, V., Zhou, H. and Choong, P.F. (2005) Localization of pigment epithelium-derived factor in growing mouse bone. Calcif. Tissue Int. 76, 146-153
57. Tombran-Tink, J. and Barnstable, C.J. (2004) Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone. Biochem. Biophys. Res. Commun. 316, 573-579
58. Li, F., Song, N., Tombran-Tink, J. and Niyibizi, C. (2014) Pigment epithelium derived factor suppresses expression of Sost/sclerostin by osteocytes: implication for its role in bone matrix mineralization. J. Cell Physiol., doi: 10.1002/jcp.24859
59. Akiyama, T., Dass, C.R., Shinoda, Y., Kawano, H., Tanaka, S. and Choong, P.F. (2010) PEDF regulates osteoclasts via osteoprotegerin and RANKL. Biochem. Biophys. Res. Commun. 391, 789-794
60. Li, F., Song, N., Tombran-Tink, J. and Niyibizi, C. (2013) Pigment epithelium derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells. Stem Cells 31, 2714-2723
61. Gattu, A.K., Swenson, E.S., Iwakiri, Y., Samuel, V.T., Troiano, N., Berry, R., Church, C.D., Rodeheffer, M.S., Carpenter, T.O. and Chung, C. (2013) Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content. FASEB J. 27, 4384-4394
62. Ek, E.T., Dass, C.R., Contreras, K.G. and Choong, P.F. (2007) PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma. J. Orthop. Res. 25, 1671-1680
63. Rauch, F., Husseini, A., Roughley, P., Glorieux, F.H. and Moffatt, P. (2012) Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI. J. Clin. Endocrinol. Metab. 97, E1550-E1556
64. Al-Jallad, H., Palomo, T., Moffatt, P., Roughley, P., Glorieux, F.H. and Rauch, F. (2014) Normal bone density and fat mass in heterozygous SERPINF1 mutation carriers. J. Clin. Endocrinol. Metab. 99, E2446-E2450
65. Farber, C.R., Reich, A., Barnes, A.M., Becerra, P., Rauch, F., Cabral, W.A., Bae, A., Quinlan, A., Glorieux, F.H., Clemens, T.L. and Marini, J.C. (2014) A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor. J. Bone Miner. Res. 29, 1402-1411
66. Baron, R. and Kneissel, M. (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19, 179-192
67. Park, K., Lee, K., Zhang, B., Zhou, T., He, X., Gao, G., Murray, A.R. and Ma, J.X. (2011) Identification of a novel inhibitor of the canonical Wnt pathway. Mol. Cell Biol. 31, 3038-3051
68. Qi, W., Yang, C., Dai, Z., Che, D., Feng, J., Mao, Y., Cheng, R., Wang, Z., He, X., Zhou, T. et al. (2014) High levels of pigment epithelium-derived factor in diabetes impair wound healing through suppression of Wnt signaling. Diabetes, doi:10.2337/db14-1111
69. Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S.E. and Wu, D. (2005) Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280, 19883-19887
70. Abramson, L.P., Browne, M., Stellmach, V., Doll, J., Cornwell, M., Reynolds, M., Arensman, R.M. and Crawford, S.E. (2006) Pigment epithelium-derived factor targets endothelial and epithelial cells in Wilms' tumor. J. Pediatr. Surg. 41, 1351-1356
71. Awad, A.S., Gao, T., Gvritishvili, A., You, H., Liu, Y., Cooper, T.K., Reeves, W.B. and Tombran-Tink, J. (2013) Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury. Am. J. Physiol. Renal Physiol. 305, F891-F900
72. Pina, A.L., Kubitza, M., Brawanski, A., Tombran-Tink, J. and Kloth, S. (2007) Expression of pigment-epithelium-derived factor during kidney development and aging. Cell Tissue Res. 329, 329-338
73. Wang, J.J., Zhang, S.X., Lu, K., Chen, Y., Mott, R., Sato, S. and Ma, J.X. (2005) Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy. Diabetes 54, 243-250
74. Shiga, Y., Miura, S., Mitsutake, R., Yamagishi, S. and Saku, K. (2011) Significance of plasma levels of pigment epithelium-derived factor as determined by multidetector row computed tomography in patients with mild chronic kidney disease and/or coronary artery disease. J. Int. Med. Res. 39, 880-890
75. Hui, E., Yeung, C.Y., Lee, P.C., Woo, Y.C., Fong, C.H., Chow, W.S., Xu, A. and Lam, K.S. (2014) Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 99, E2169-E2177
76. Karakousis, P.C., John, S.K., Behling, K.C., Surace, E.M., Smith, J.E., Hendrickson, A., Tang, W.X., Bennett, J. and Milam, A.H. (2001) Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol. Vis. 7, 154-163
77. Kozulin, P., Natoli, R., Bumsted O'Brien, K.M., Madigan, M.C. and Provis, J.M. (2010) The cellular expression of antiangiogenic factors in fetal primate macula. Invest. Ophthalmol. Vis. Sci. 51, 4298-4306
78. Becerra, S.P., Fariss, R.N., Wu, Y.Q., Montuenga, L.M., Wong, P. and Pfeffer, B.A. (2004) Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution. Exp. Eye Res. 78, 223-234
79. Sonoda, S., Sreekumar, P.G., Kase, S., Spee, C., Ryan, S.J., Kannan, R. and Hinton, D.R. (2010) Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: relevance to age-related macular degeneration. Aging (Albany NY) 2, 28-42
80. Zhu, D., Deng, X., Spee, C., Sonoda, S., Hsieh, C.L., Barron, E., Pera, M. and Hinton, D.R. (2011) Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival. Invest. Ophthalmol. Vis. Sci. 52, 1573-1585
81. Wu, Y.Q., Notario, V., Chader, G.J. and Becerra, S.P. (1995) Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes. Protein Expr. Purif. 6, 447-456
82. Wu, Y.Q. and Becerra, S.P. (1996) Proteolytic activity directed toward pigment epithelium-derived factor in vitreous of bovine eyes. Implications of proteolytic processing. Invest. Ophthalmol. Vis. Sci. 37, 1984-1993
83. Tombran-Tink, J., Shivaram, S.M., Chader, G.J., Johnson, L.V. and Bok, D. (1995) Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J. Neurosci. 15, 4992-5003
84. Behling, K.C., Surace, E.M. and Bennett, J. (2002) Pigment epithelium-derived factor expression in the developing mouse eye. Mol. Vis. 8, 449-454
85. Ogata, N., Wada, M., Otsuji, T., Jo, N., Tombran-Tink, J. and Matsumura, M. (2002) Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43, 1168-1175
86. Sorenson, C.M., Wang, S., Gendron, R., Paradis, H. and Sheibani, N. (2013) Thrombospondin-1 deficiency exacerbates the pathogenesis of diabetic retinopathy. J. Diabetes Metab, doi:10.4172/2155-6156.S12-005
87. Park, K., Jin, J., Hu, Y., Zhou, K. and Ma, J.X. (2011) Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization. Am. J. Pathol. 178, 688-698
88. Haurigot, V., Villacampa, P., Ribera, A., Bosch, A., Ramos, D., Ruberte, J. and Bosch, F. (2012) Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy. PLoS ONE 7, e41511
89. Mori, K., Duh, E., Gehlbach, P., Ando, A., Takahashi, K., Pearlman, J., Mori, K., Yang, H.S., Zack, D.J., Ettyreddy, D. et al. (2001) Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J. Cell Physiol. 188, 253-263
90. Saishin, Y., Silva, R.L., Saishin, Y., Kachi, S., Aslam, S., Gong, Y.Y., Lai, H., Carrion, M., Harris, B., Hamilton, M. et al. (2005) Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye. Hum. Gene Ther. 16, 473-478
91. Amaral, J. and Becerra, S.P. (2010) Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 51, 1318-1326
92. Kuo, C.N., Chen, C.Y., Chen, S.N., Yang, L.C., Lai, L.J., Lai, C.H., Chen, M.F., Hung, C.H. and Chen, C.H. (2013) Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile interaction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model. Int. J. Mol. Sci. 14, 8291-8305
93. Matsui, T., Nishino, Y., Maeda, S. and Yamagishi, S. (2012) PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression. Microvasc. Res. 84, 105-108
94. Kuo, C.N., Yang, L.C., Yang, C.T., Lai, C.H., Chen, M.F., Chen, C.Y., Chen, C.H., Wu, P.C., Kou, H.K., Chen, Y.J. et al. (2009) Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile interaction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis. Exp. Eye Res. 89, 678-685
95. Volpert, K.N., Tombran-Tink, J., Barnstable, C. and Layer, P.G. (2009) PEDF and GDNF are key regulators of photoreceptor development and retinal neurogenesis in reaggregates from chick embryonic retina. J. Ocul. Biol. Dis. Infor. 2, 1-11
96. Malchiodi-Albedi, F., Feher, J., Caiazza, S., Formisano, G., Perilli, R., Falchi, M., Petrucci, T.C., Scorcia, G. and Tombran-Tink, J. (1998) PEDF (pigment epithelium-derived factor) promotes increase and maturation of pigment granules in pigment epithelial cells in neonatal albino rat retinal cultures. Int. J. Dev. Neurosci. 16, 423-432
97. Arnhold, S., Heiduschka, P., Klein, H., Absenger, Y., Basnaoglu, S., Kreppel, F., Henke-Fahle, S., Kochanek, S., Bartz-Schmidt, K.U., Addicks, K. and Schraermeyer, U. (2006) Adenovirally transduced bone marrow stromal cells differentiate into pigment epithelial cells and induce rescue effects in RCS rats. Invest. Ophthalmol. Vis. Sci. 47, 4121-4129
98. Cayouette, M., Smith, S.B., Becerra, S.P. and Gravel, C. (1999) Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol. Dis. 6, 523-532
99. Cao, W., Tombran-Tink, J., Chen, W., Mrazek, D., Elias, R. and McGinnis, J.F. (1999) Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J. Neurosci. Res. 57, 789-800
100. Wang, Y., Subramanian, P., Shen, D., Tuo, J., Becerra, S.P. and Chan, C.C. (2013) Pigment epithelium-derived factor reduces apoptosis and pro-inflammatory cytokine gene expression in a murine model of focal retinal degeneration. ASN NEURO 5, e00126
101. Cao, W., Tombran-Tink, J., Elias, R., Sezate, S., Mrazek, D. and McGinnis, J.F. (2001) In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 42, 1646-1652
102. Imai, D., Yoneya, S., Gehlbach, P.L., Wei, L.L. and Mori, K. (2005) Intraocular gene transfer of pigment epithelium-derived factor rescues photoreceptors from light-induced cell death. J. Cell Physiol. 202, 570-578
103. Jablonski, M.M., Tombran-Tink, J., Mrazek, D.A. and Iannaccone, A. (2000) Pigment epithelium-derived factor supports normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium removal. J. Neurosci. 20, 7149-7157
104. Subramanian, P., Locatelli-Hoops, S., Kenealey, J., DesJardin, J., Notari, L. and Becerra, S.P. (2013) Pigment epithelium-derived factor (PEDF) prevents retinal cell death via PEDF receptor (PEDF-R): identification of a functional ligand binding site. J. Biol. Chem. 288, 23928-23942
105. Folkman, J. and Klagsbrun, M. (1987) Angiogenic factors. Science 235, 442-447
106. Wietecha, M.S., Cerny, W.L. and DiPietro, L.A. (2013) Mechanisms of vessel regression: toward an understanding of the resolution of angiogenesis. Curr. Top Microbiol. Immunol. 367, 3-32
107. Hoshina, D., Abe, R., Yamagishi, S.I. and Shimizu, H. (2010) The role of PEDF in tumor growth and metastasis. Curr. Mol. Med. 10, 292-295
108. Manalo, K.B., Choong, P.F., Becerra, S.P. and Dass, C.R. (2011) Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective. Expert. Opin. Ther. Pat. 21, 121-130
109. Becerra, S.P. and Notario, V. (2013) The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential. Nat. Rev. Cancer 13, 258-271
110. Rychli, K., Huber, K. and Wojta, J. (2009) Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease. Expert Opin. Ther. Targets. 13, 1295-1302
111. Liu, J.T., Chen, Y.L., Chen, W.C., Chen, H.Y., Lin, Y.W., Wang, S.H., Man, K.M., Wan, H.M., Yin, W.H., Liu, P.L. and Chen, Y.H. (2012) Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J. Biomed. Biotechnol. 2012, 871272
112. Notari, L., Baladron, V., Aroca-Aguilar, J.D., Balko, N., Heredia, R., Meyer, C., Notario, P.M., Saravanamuthu, S., Nueda, M.L., Sanchez-Sanchez, F. et al. (2006) Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor. J. Biol. Chem. 281, 38022-38037
113. Alberdi, E., Aymerich, M.S. and Becerra, S.P. (1999) Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor. J. Biol. Chem. 274, 31605-31612
114. Subramanian, P., Notario, P.M. and Becerra, S.P. (2010) Pigment epithelium-derived factor receptor (PEDF-R): a plasma membrane-linked phospholipase with PEDF binding affinity. Adv. Exp. Med. Biol. 664, 29-37
115. Desjardin, J.T., Becerra, S.P. and Subramanian, P. (2013) Searching for alternatively spliced variants of phospholipase domain-containing 2 (Pnpla2), a novel gene in the retina. J. Clin. Exp. Ophthalmol. 4, 295
116. Aymerich, M.S., Alberdi, E.M., Martinez, A. and Becerra, S.P. (2001) Evidence for pigment epithelium-derived factor receptors in the neural retina. Invest. Ophthalmol. Vis. Sci. 42, 3287-3293
117. Subramanian, P., Rapp, M. and Becerra, S.P. (2012) Identification of pigment epithelium-derived factor receptor (PEDF-R) antibody epitopes. Adv. Exp. Med. Biol. 723, 799-805
118. Hirsch, J., Johnson, C.L., Nelius, T., Kennedy, R., Riese, W. and Filleur, S. (2011) PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFkappaB and PPARgamma. Cytokine 55, 202-210
119. Ladhani, O., Sanchez-Martinez, C., Orgaz, J.L., Jimenez, B. and Volpert, O.V. (2011) Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis. Neoplasia 13, 633-642
120. Chavan, S.S., Hudson, L.K., Li, J.H., Ochani, M., Harris, Y., Patel, N.B., Katz, D., Scheinerman, J.A., Pavlov, V.A. and Tracey, K.J. (2012) Identification of pigment epithelium-derived factor as an adipocyte-derived inflammatory factor. Mol. Med. 18, 1161-1168
121. Moreno-Navarrete, J.M., Touskova, V., Sabater, M., Mraz, M., Drapalova, J., Ortega, F., Serrano, M., Catalan, V., Gomez-Ambrosi, J., Ortiz, M.R. et al. (2013) Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance. Int. J. Obes. (Lond). 37, 1230-1237
122. Gonzalez, R., Jennings, L.L., Knuth, M., Orth, A.P., Klock, H.E., Ou, W., Feuerhelm, J., Hull, M.V., Koesema, E., Wang, Y. et al. (2010) Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency. Proc. Natl. Acad. Sci. U.S.A. 107, 3552-3557
123. Rapp, M., Woo, G., Al-Ubaidi, M.R., Becerra, S.P. and Subramanian, P. (2014) Pigment epithelium-derived factor protects cone photoreceptor-derived 661W cells from light damage through Akt activation. Adv. Exp. Med. Biol. 801, 813-820
124. Aurora, A.B., Biyashev, D., Mirochnik, Y., Zaichuk, T.A., Sanchez-Martinez, C., Renault, M.A., Losordo, D. and Volpert, O.V. (2010) NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement. Blood 116, 475-484
125. Bernard, A., Gao-Li, J., Franco, C.A., Bouceba, T., Huet, A. and Li, Z. (2009) Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor. J. Biol. Chem. 284, 10480-10490
126. Konson, A., Pradeep, S., D'Acunto, C.W. and Seger, R. (2011) Pigment epithelium-derived factor and its phosphomimetic mutant induce JNK-dependent apoptosis and p38-mediated migration arrest. J. Biol. Chem. 286, 3540-3551
127. Notari, L., Arakaki, N., Mueller, D., Meier, S., Amaral, J. and Becerra, S.P. (2010) Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase. FEBS J. 277, 2192-2205
128. Willnow, T.E., Goldstein, J.L., Orth, K., Brown, M.S. and Herz, J. (1992) Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267, 26172-26180
129. Conese, M., Olson, D. and Blasi, F. (1994) Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and alpha 2-macroglobulin receptor. J. Biol. Chem. 269, 17886-17892
130. Poller, W., Willnow, T.E., Hilpert, J. and Herz, J. (1995) Differential recognition of alpha 1-antitrypsin-elastase and alpha 1-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein. J. Biol. Chem. 270, 2841-2845
131. Zhang, B., Zhou, K.K. and Ma, J.X. (2010) Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. Diabetes 59, 1809-1816
132. Hu, Y., Chen, Y., Lin, M., Lee, K., Mott, R.A. and Ma, J.X. (2013) Pathogenic role of the Wnt signaling pathway activation in laser-induced choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 54, 141-154
133. Lee, K., Hu, Y., Ding, L., Chen, Y., Takahashi, Y., Mott, R. and Ma, J.X. (2012) Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy. Diabetes 61, 2948-2957
134. Meyer, C., Notari, L. and Becerra, S.P. (2002) Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J. Biol. Chem. 277, 45400-45407
135. Hosomichi, J., Yasui, N., Koide, T., Soma, K. and Morita, I. (2005) Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor. Biochem. Biophys. Res. Commun. 335, 756-761
136. Kozaki, K., Miyaishi, O., Koiwai, O., Yasui, Y., Kashiwai, A., Nishikawa, Y., Shimizu, S. and Saga, S. (1998) Isolation, purification, and characterization of a collagen-associated serpin, caspin, produced by murine colon adenocarcinoma cells. J. Biol. Chem. 273, 15125-15130
137. Alberdi, E., Hyde, C.C. and Becerra, S.P. (1998) Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Biochemistry 37, 10643-10652
138. Becerra, S.P., Perez-Mediavilla, L.A., Weldon, J.E., Locatelli-Hoops, S., Senanayake, P., Notari, L., Notario, V. and Hollyfield, J.G. (2008) Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site. J. Biol. Chem. 283, 33310-33320
139. Valnickova, Z., Petersen, S.V., Nielsen, S.B., Otzen, D.E. and Enghild, J.J. (2007) Heparin binding induces a conformational change in pigment epithelium-derived factor. J. Biol. Chem. 282, 6661-6667
140. Alberdi, E.M., Weldon, J.E. and Becerra, S.P. (2003) Glycosaminoglycans in human retinoblastoma cells: heparan sulfate, a modulator of the pigment epithelium-derived factor-receptor interactions. BMC Biochem. 4, 1
141. Martin, A., Komada, M.R. and Sane, D.C. (2003) Abnormal angiogenesis in diabetes mellitus. Med. Res. Rev. 23, 117-145
142. Nyengaard, J.R. and Rasch, R. (1993) The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 36, 189-194
143. Mohan, N., Monickaraj, F., Balasubramanyam, M., Rema, M. and Mohan, V. (2012) Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. J. Diabetes Complications 26, 435-441
144. Wang, H., Feng, L., Hu, J.W., Xie, C.L. and Wang, F. (2012) Characterisation of the vitreous proteome in proliferative diabetic retinopathy. Proteome. Sci. 10, 15
145. Huber, M. and Wachtlin, J. (2012) Vitreous levels of proteins implicated in angiogenesis are modulated in patients with retinal or choroidal neovascularization. Ophthalmologica 228, 188-193
146. Zheng, B., Li, T., Chen, H., Xu, X. and Zheng, Z. (2011) Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 152, 1039-1043
147. Matsunaga, N., Chikaraishi, Y., Izuta, H., Ogata, N., Shimazawa, M., Matsumura, M. and Hara, H. (2008) Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Ophthalmology 115, 1916-1922
148. Murugeswari, P., Shukla, D., Rajendran, A., Kim, R., Namperumalsamy, P. and Muthukkaruppan, V. (2008) Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Retina 28, 817-824
149. Garcia-Ramirez, M., Canals, F., Hernandez, C., Colome, N., Ferrer, C., Carrasco, E., Garcia-Arumi, J. and Simo, R. (2007) Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 50, 1294-1303
150. Wang, J.J., Zhang, S.X., Mott, R., Knapp, R.R., Cao, W., Lau, K. and Ma, J.X. (2006) Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities. Diabetes 55, 1678-1685
151. Arimura, T., Miura, S., Sugihara, M., Iwata, A., Yamagishi, S. and Saku, K. (2011) Association between plasma levels of pigment epithelium-derived factor and renal dysfunction in patients with coronary artery disease. Cardiol. J. 18, 515-520
152. Yoshida, Y., Yamagishi, S., Matsui, T., Jinnouchi, Y., Fukami, K., Imaizumi, T. and Yamakawa, R. (2009) Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy. Diabetes Metab. Res. Rev. 25, 678-686
153. Zhang, S.X., Wang, J.J., Gao, G., Parke, K. and Ma, J.X. (2006) Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J. Mol. Endocrinol. 37, 1-12
154. Liu, Y., Leo, L.F., McGregor, C., Grivitishvili, A., Barnstable, C.J. and Tombran-Tink, J. (2012) Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice. Mol. Med. 18, 1387-1401
155. Wang, J.J., Zhang, S.X., Mott, R., Chen, Y., Knapp, R.R., Cao, W. and Ma, J.X. (2008) Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 294, F1166-F1173
156. Rundhaug, J.E. (2005) Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 9, 267-285
157. Yafai, Y., Lange, J., Wiedemann, P., Reichenbach, A. and Eichler, W. (2007) Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions. Glia 55, 642-651
158. Hutchings, H., Maitre-Boube, M., Tombran-Tink, J. and Plouet, J. (2002) Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes. Biochem. Biophys. Res. Commun. 294, 764-769
159. Biyashev, D., Veliceasa, D., Kwiatek, A., Sutanto, M.M., Cohen, R.N. and Volpert, O.V. (2010) Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma (PPARgamma). J. Biol. Chem. 285, 13517-13524
160. Dejana, E. (2010) The role of Wnt signaling in physiological and pathological angiogenesis. Circ. Res. 107, 943-952
161. Zhang, X., Gaspard, J.P. and Chung, D.C. (2001) Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 61, 6050-6054
162. Brabletz, T., Jung, A., Dag, S., Hlubek, F. and Kirchner, T. (1999) β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 155, 1033-1038
163. Crawford, H.C., Fingleton, B.M., Rudolph-Owen, L.A., Goss, K.J., Rubinfeld, B., Polakis, P. and Matrisian, L.M. (1999) The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 18, 2883-2891
164. Wu, B., Crampton, S.P. and Hughes, C.C. (2007) Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26, 227-239
165. Yamagishi, S., Nakamura, K., Matsui, T., Inagaki, Y., Takenaka, K., Jinnouchi, Y., Yoshida, Y., Matsuura, T., Narama, I., Motomiya, Y. et al. (2006) Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J. Biol. Chem. 281, 20213-20220
166. Yamagishi, S., Matsui, T., Nakamura, K., Yoshida, T., Takeuchi, M., Inoue, H., Yoshida, Y. and Imaizumi, T. (2007) Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. Ophthalmic Res. 39, 92-97
167. Yamagishi, S., Inagaki, Y., Nakamura, K., Abe, R., Shimizu, T., Yoshimura, A. and Imaizumi, T. (2004) Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J. Mol. Cell Cardiol. 37, 497-506
168. Yamagishi, S., Nakamura, K., Ueda, S., Kato, S. and Imaizumi, T. (2005) Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res. 320, 437-445
169. Zheng, Z., Chen, H., Zhao, H., Liu, K., Luo, D., Chen, Y., Chen, Y., Yang, X., Gu, Q. and Xu, X. (2010) Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro. Invest. Ophthalmol. Vis. Sci. 51, 64-71
170. Ejaz, S., Chekarova, I., Ejaz, A., Sohail, A. and Lim, C.W. (2008) Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes. Metab. 10, 53-63
171. Zhang, S.X., Wang, J.J., Dashti, A., Wilson, K., Zou, M.H., Szweda, L., Ma, J.X. and Lyons, T.J. (2008) Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein. J. Mol. Endocrinol. 41, 135-143
172. Yamagishi, S., Inagaki, Y., Amano, S., Okamoto, T., Takeuchi, M. and Makita, Z. (2002) Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem. Biophys. Res. Commun. 296, 877-882
173. Amano, S., Yamagishi, S., Inagaki, Y., Nakamura, K., Takeuchi, M., Inoue, H. and Imaizumi, T. (2005) Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes. Microvasc. Res. 69, 45-55
174. Enge, M., Bjarnegard, M., Gerhardt, H., Gustafsson, E., Kalen, M., Asker, N., Hammes, H.P., Shani, M., Fassler, R. and Betsholtz, C. (2002) Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 21, 4307-4316
175. Yamagishi, S., Nakamura, K., Takenaka, K., Matsui, T., Jinnouchi, Y. and Imaizumi, T. (2005) Pigment epithelium-derived factor (PEDF) promotes growth of pericytes through autocrine production of platelet-derived growth factor-B. Microvasc. Res. 69, 128-134
176. Wang, G.L., Jiang, B.H., Rue, E.A. and Semenza, G.L. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510-5514
177. Pugh, C.W. and Ratcliffe, P.J. (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677-684
178. Ke, Q. and Costa, M. (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 70, 1469-1480
179. Smith, L.E., Wesolowski, E., McLellan, A., Kostyk, S.K., D'Amato, R., Sullivan, R. and D'Amore, P.A. (1994) Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101-111
180. Mowat, F.M., Luhmann, U.F., Smith, A.J., Lange, C., Duran, Y., Harten, S., Shukla, D., Maxwell, P.H., Ali, R.R. and Bainbridge, J.W. (2010) HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS ONE 5, e11103
181. Notari, L., Miller, A., Martinez, A., Amaral, J., Ju, M., Robinson, G., Smith, L.E. and Becerra, S.P. (2005) Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest. Ophthalmol. Vis. Sci. 46, 2736-2747
182. Miller, H., Miller, B., Ishibashi, T. and Ryan, S.J. (1990) Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest. Ophthalmol. Vis. Sci. 31, 899-908
183. Mori, K., Gehlbach, P., Yamamoto, S., Duh, E., Zack, D.J., Li, Q., Berns, K.I., Raisler, B.J., Hauswirth, W.W. and Campochiaro, P.A. (2002) AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43, 1994-2000
184. Hamilton, M.M., Byrnes, G.A., Gall, J.G., Brough, D.E., King, C.R. and Wei, L.L. (2008) Alternate serotype adenovector provides long-term therapeutic gene expression in the eye. Mol. Vis. 14, 2535-2546
185. Liu, Y., Cox, S.R., Morita, T. and Kourembanas, S. (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ. Res. 77, 638-643
186. Shweiki, D., Itin, A., Soffer, D. and Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845
187. Zhang, Z., Neiva, K.G., Lingen, M.W., Ellis, L.M. and Nor, J.E. (2010) VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ. 17, 499-512
188. Cai, J., Jiang, W.G., Grant, M.B. and Boulton, M. (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J. Biol. Chem. 281, 3604-3613
189. Kendall, R.L. and Thomas, K.A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 10705-10709
190. Zou, D., Zhang, Z., He, J., Zhang, K., Ye, D., Han, W., Zhou, J., Wang, Y., Li, Q., Liu, X. et al. (2012) Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1alpha mediated BMSCs. Biomaterials 33, 2097-2108
191. Calvani, M., Rapisarda, A., Uranchimeg, B., Shoemaker, R.H. and Melillo, G. (2006) Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107, 2705-2712
192. Zaichuk, T.A., Shroff, E.H., Emmanuel, R., Filleur, S., Nelius, T. and Volpert, O.V. (2004) Nuclear factor of activated T cells balances angiogenesis activation and inhibition. J. Exp. Med. 199, 1513-1522
193. Ben-Yosef, Y., Lahat, N., Shapiro, S., Bitterman, H. and Miller, A. (2002) Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ. Res. 90, 784-791
194. Rodrigues, M., Xin, X., Jee, K., Babapoor-Farrokhran, S., Kashiwabuchi, F., Ma, T., Bhutto, I., Hassan, S.J., Daoud, Y., Baranano, D. et al. (2013) VEGF secreted by hypoxic Muller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes 62, 3863-3873
195. Cheng, X.W., Kuzuya, M., Kim, W., Song, H., Hu, L., Inoue, A., Nakamura, K., Di, Q., Sasaki, T., Tsuzuki, M. et al. (2010) Exercise training stimulates ischemia-induced neovascularization via phosphatidylinositol 3-kinase/Akt-dependent hypoxia-induced factor-1 alpha reactivation in mice of advanced age. Circulation 122, 707-716
196. Yamamoto, Y., Osanai, T., Nishizaki, F., Sukekawa, T., Izumiyama, K., Sagara, S. and Okumura, K. (2012) Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-alpha. Heart Vessels 27, 624-633
197. Bauer, A.T., Burgers, H.F., Rabie, T. and Marti, H.H. (2010) Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J. Cereb. Blood Flow Metab. 30, 837-848
198. Hollborn, M., Stathopoulos, C., Steffen, A., Wiedemann, P., Kohen, L. and Bringmann, A. (2007) Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest. Ophthalmol. Vis. Sci. 48, 4360-4367
199. Kaluz, S., Kaluzova, M. and Stanbridge, E.J. (2008) Rational design of minimal hypoxia-inducible enhancers. Biochem. Biophys. Res. Commun. 370, 613-618
200. Patel, N., Sundaram, N., Yang, M., Madigan, C., Kalra, V.K. and Malik, P. (2010) Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD). J. Biol. Chem. 285, 16713-16722
201. Liao, H., Hyman, M.C., Lawrence, D.A. and Pinsky, D.J. (2007) Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J. 21, 935-949
202. Jung, S.Y., Song, H.S., Park, S.Y., Chung, S.H. and Kim, Y.J. (2011) Pyruvate promotes tumor angiogenesis through HIF-1-dependent PAI-1 expression. Int. J. Oncol. 38, 571-576
203. Matsui, T., Higashimoto, Y., Taira, J. and Yamagishi, S. (2013) Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells. Biochem. Biophys. Res. Commun. 441, 405-410
204. Yamagishi, S., Matsui, T., Nakamura, K. and Takenaka, K. (2009) Administration of pigment epithelium-derived factor prolongs bleeding time by suppressing plasminogen activator inhibitor-1 activity and platelet aggregation in rats. Clin. Exp. Med. 9, 73-76
205. Bai, Y.J., Huang, L.Z., Xu, X.L., Du, W., Zhou, A.Y., Yu, W.Z. and Li, X.X. (2012) Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization. J. Pharmacol. Exp. Ther. 342, 131-139
206. Konson, A., Pradeep, S. and Seger, R. (2010) Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents. Cancer Res. 70, 6247-6257
207. Yang, J., Chen, S., Huang, X., Han, J., Wang, Q., Shi, D., Cheng, R., Gao, G. and Yang, X. (2010) Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis. Cancer Biol. Ther. 9, 967-974
208. Ho, T.C., Chen, S.L., Yang, Y.C., Liao, C.L., Cheng, H.C. and Tsao, Y.P. (2007) PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc. Res. 76, 213-223
209. Volpert, O.V., Zaichuk, T., Zhou, W., Reiher, F., Ferguson, T.A., Stuart, P.M., Amin, M. and Bouck, N.P. (2002) Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat. Med. 8, 349-357
210. Ho, T.C., Chen, S.L., Yang, Y.C., Lo, T.H., Hsieh, J.W., Cheng, H.C. and Tsao, Y.P. (2009) Cytosolic phospholipase A2-α is an early apoptotic activator in PEDF-induced endothelial cell apoptosis. Am. J. Physiol. Cell Physiol. 296, C273-C284
211. Mori, K., Gehlbach, P., Ando, A., McVey, D., Wei, L. and Campochiaro, P.A. (2002) Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 43, 2428-2434
212. Mirochnik, Y., Aurora, A., Schulze-Hoepfner, F.T., Deabes, A., Shifrin, V., Beckmann, R., Polsky, C. and Volpert, O.V. (2009) Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth. Clin. Cancer Res. 15, 1655-1663
213. Filleur, S., Volz, K., Nelius, T., Mirochnik, Y., Huang, H., Zaichuk, T.A., Aymerich, M.S., Becerra, S.P., Yap, R., Veliceasa, D. et al. (2005) Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res. 65, 5144-5152
214. Gong, Q., Yang, X., Cai, W., Gao, G. and Yang, Z. (2010) Expression and purification of functional epitope of pigment epithelium-derived factor in E. coli with inhibiting effect on endothelial cells. Protein J. 29, 167-173
215. Ju, S.T., Panka, D.J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D.H., Stanger, B.Z. and Marshak-Rothstein, A. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448
216. Kaplan, H.J., Leibole, M.A., Tezel, T. and Ferguson, T.A. (1999) Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat. Med. 5, 292-297
217. Barreiro, R., Schadlu, R., Herndon, J., Kaplan, H.J. and Ferguson, T.A. (2003) The role of Fas-FasL in the development and treatment of ischemic retinopathy. Invest. Ophthalmol. Vis. Sci. 44, 1282-1286
218. Chen, L., Zhang, S.S., Barnstable, C.J. and Tombran-Tink, J. (2006) PEDF induces apoptosis in human endothelial cells by activating p38 MAP kinase dependent cleavage of multiple caspases. Biochem. Biophys. Res. Commun. 348, 1288-1295
219. Doyon, G., St-Jean, S., Darsigny, M., Asselin, C. and Boudreau, F. (2009) Nuclear receptor co-repressor is required to maintain proliferation of normal intestinal epithelial cells in culture and down-modulates the expression of pigment epithelium-derived factor. J. Biol. Chem. 284, 25220-25229
220. Tombran-Tink, J., Lara, N., Apricio, S.E., Potluri, P., Gee, S., Ma, J.X., Chader, G. and Barnstable, C.J. (2004) Retinoic acid and dexamethasone regulate the expression of PEDF in retinal and endothelial cells. Exp. Eye Res. 78, 945-955
221. Uchida, H., Hayashi, H., Kuroki, M., Uno, K., Yamada, H., Yamashita, Y., Tombran-Tink, J., Kuroki, M. and Oshima, K. (2005) Vitamin A up-regulates the expression of thrombospondin-1 and pigment epithelium-derived factor in retinal pigment epithelial cells. Exp. Eye Res. 80, 23-30
222. Cheung, L.W., Au, S.C., Cheung, A.N., Ngan, H.Y., Tombran-Tink, J., Auersperg, N. and Wong, A.S. (2006) Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology 147, 4179-4191
223. Leung, K.W., Cheung, L.W., Pon, Y.L., Wong, R.N., Mak, N.K., Fan, T.P., Au, S.C., Tombran-Tink, J. and Wong, A.S. (2007) Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor. Br. J. Pharmacol. 152, 207-215
224. Li, C., Tang, Y., Li, F., Turner, S., Li, K., Zhou, X., Centola, M., Yan, X. and Cao, W. (2006) 17β-Estradiol (betaE2) protects human retinal Muller cell against oxidative stress in vitro: evaluation of its effects on gene expression by cDNA microarray. Glia 53, 392-400
225. Chuderland, D., Ben-Ami, I., Friedler, S., Hasky, N., Ninio-Many, L., Goldberg, K., Bar-Joseph, H., Grossman, H. and Shalgi, R. (2014) Hormonal regulation of pigment epithelium-derived factor (PEDF) expression in the endometrium. Mol. Cell Endocrinol. 390, 85-92
226. Parvathaneni, K., Grigsby, J.G., Betts, B.S. and Tsin, A.T. (2013) Estrogen-induced retinal endothelial cell proliferation: possible involvement of pigment epithelium-derived factor and phosphoinositide 3-kinase/mitogen-activated protein kinase pathways. J. Ocul. Pharmacol. Ther. 29, 27-32
227. Zhou, Y., Xu, F., Deng, H., Bi, Y., Sun, W., Zhao, Y., Chen, Z. and Weng, J. (2013) PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11beta-HSD1. PLoS ONE 8, e84016
228. Tong, J.P., Lam, D.S., Chan, W.M., Choy, K.W., Chan, K.P. and Pang, C.P. (2006) Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells. Mol. Vis. 12, 1490-1495
229. Perruccio, E.M., Rowlette, L.L., Comes, N., Locatelli-Hoops, S., Notari, L., Becerra, S.P. and Borras, T. (2008) Dexamethasone increases pigment epithelium-derived factor in perfused human eyes. Curr. Eye Res. 33, 507-515
230. Fernandez-Barral, A., Orgaz, J.L., Baquero, P., Ali, Z., Moreno, A., Tiana, M., Gomez, V., Riveiro-Falkenbach, E., Canadas, C., Zazo, S. et al. (2014) Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma. Neoplasia 16, 529-542
231. Ma, X., Pan, L., Jin, X., Dai, X., Li, H., Wen, B., Chen, Y., Ma, A., Qu, J. and Hou, L. (2012) Microphthalmia-associated transcription factor acts through PEDF to regulate RPE cell migration. Exp. Cell Res. 318, 251-261
232. Petersen, S.V., Valnickova, Z. and Enghild, J.J. (2003) Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem. J. 374, 199-206
233. Maik-Rachline, G., Shaltiel, S. and Seger, R. (2005) Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor. Blood 105, 670-678
234. Maik-Rachline, G. and Seger, R. (2006) Variable phosphorylation states of pigment-epithelium-derived factor differentially regulate its function. Blood 107, 2745-2752
235. Duh, E.J., Yang, H.S., Suzuma, I., Miyagi, M., Youngman, E., Mori, K., Katai, M., Yan, L., Suzuma, K., West, K. et al. (2002) Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 43, 821-829
236. Subramanian, P., Deshpande, M., Locatelli-Hoops, S., Moghaddam-Taaheri, S., Gutierrez, D., Fitzgerald, D.P., Guerrier, S., Rapp, M., Notario, V. and Becerra, S.P. (2012) Identification of pigment epithelium-derived factor protein forms with distinct activities on tumor cell lines. J. Biomed. Biotechnol. 2012, 425907
237. Wang, S., Gottlieb, J.L., Sorenson, C.M. and Sheibani, N. (2009) Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes. Arch. Ophthalmol. 127, 507-513
238. Shao, H., Schvartz, I. and Shaltiel, S. (2003) Secretion of pigment epithelium-derived factor. Mutagenic study. Eur. J. Biochem. 270, 822-831
239. Xiao, Q., Zeng, S., Lv, M. and Ling, S. (2008) Small hairpin loop RNA targeting HIF-1alpha down-regulates VEGF and up-regulates PEDF in human retinal pigment epithelial cells under hypoxic condition. J. Huazhong. Univ. Sci. Technolog. Med. Sci. 28, 460-464
240. Bandyopadhyay, M. and Rohrer, B. (2012) Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement. Invest. Ophthalmol. Vis. Sci. 53, 1953-1961
241. Fernandez-Barral, A., Orgaz, J.L., Gomez, V., del Peso, L., Calzada, M.J. and Jimenez, B. (2012) Hypoxia negatively regulates antimetastatic PEDF in melanoma cells by a hypoxia inducible factor-independent, autophagy dependent mechanism. PLoS ONE 7, e32989
242. Rasmussen, H., Chu, K.W., Campochiaro, P., Gehlbach, P.L., Haller, J.A., Handa, J.T., Nguyen, Q.D. and Sung, J.U. (2001) Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Hum. Gene. Ther. 12, 2029-2032
243. Conti, A., Ricchiuto, P., Iannaccone, S., Sferrazza, B., Cattaneo, A., Bachi, A., Reggiani, A., Beltramo, M. and Alessio, M. (2005) Pigment epithelium-derived factor is differentially expressed in peripheral neuropathies. Proteomics 5, 4558-4567
244. Craik, D.J., Fairlie, D.P., Liras, S. and Price, D. (2013) The future of peptide-based drugs. Chem. Biol. Drug Des. 81, 136-147
245. Deshpande, M., Notari, L., Subramanian, P., Notario, V. and Becerra, S.P. (2012) Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity. Int. J. Oncol. 41, 219-227
246. Becerra, S.P., Palmer, I., Kumar, A., Steele, F., Shiloach, J., Notario, V. and Chader, G.J. (1993) Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli. A functionally active neurotrophic factor. J. Biol. Chem. 268, 23148-23156
247. Bilak, M.M., Becerra, S.P., Vincent, A.M., Moss, B.H., Aymerich, M.S. and Kuncl, R.W. (2002) Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J. Neurosci. 22, 9378-9386
248. Smith, N.D., Schulze-Hoepfner, F.T., Veliceasa, D., Filleur, S., Shareef, S., Huang, L., Huang, X.M. and Volpert, O.V. (2008) Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism. J. Urol. 179, 2427-2434
249. Sanagi, T., Yabe, T. and Yamada, H. (2010) Adenoviral gene delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic acid-induced excitotoxicity. J. Neuropathol. Exp. Neurol. 69, 224-233
250. Li, H., Tran, V.V., Hu, Y., Mark Saltzman, W., Barnstable, C.J. and Tombran-Tink, J. (2006) A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres. Exp. Eye Res. 83, 824-833
251. Longeras, R., Farjo, K., Ihnat, M. and Ma, J.X. (2012) A PEDF-derived peptide inhibits retinal neovascularization and blocks mobilization of bone marrow-derived endothelial progenitor cells. Exp. Diabetes Res. 2012, 518426
252. Esipov, R.S., Beirakhova, K.A., Chupova, L.A., Likhvantseva, V.K., Stepanova, E.V. and Miroshnikov, A.I. (2012) Recombinant fragment of pigment epithelium-derived factor (44-77) prevents pathological corneal neovascularization. Bioorg. Khim. 38, 78-85
253. Liu, H., Ren, J.G., Cooper, W.L., Hawkins, C.E., Cowan, M.R. and Tong, P.Y. (2004) Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc. Natl. Acad. Sci. U.S.A. 101, 6605-6610
254. Sanchez-Sanchez, F., Aroca-Aguilar, J.D., Segura, I., Ramirez-Castillejo, C., Riese, H.H., Coca-Prados, M. and Escribano, J. (2008) Expression and purification of functional recombinant human pigment epithelium-derived factor (PEDF) secreted by the yeast Pichia pastoris. J. Biotechnol. 134, 193-201
255. Sanagi, T., Yabe, T. and Yamada, H. (2005) The regulation of pro-inflammatory gene expression induced by pigment epithelium-derived factor in rat cultured microglial cells. Neurosci. Lett. 380, 105-110
256. Takanohashi, A., Yabe, T. and Schwartz, J.P. (2005) Pigment epithelium-derived factor induces the production of chemokines by rat microglia. Glia 51, 266-278
257. Yabe, T., Sanagi, T., Schwartz, J.P. and Yamada, H. (2005) Pigment epithelium-derived factor induces pro-inflammatory genes in neonatal astrocytes through activation of NF-kappa B and CREB. Glia 50, 223-234
258. Li, S., Fu, X.A., Zhou, X.F., Chen, Y.Y. and Chen, W.Q. (2012) Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy. Int. J. Ophthalmol. 5, 726-730